Abstract:Purpose High‐quality CBCT and AI‐enhanced adaptive planning techniques allow CBCT‐guided stereotactic adaptive radiotherapy (CT‐STAR) to account for inter‐fractional anatomic changes. Studies of intra‐fractional respiratory motion management with a surface imaging solution for CT‐STAR have not been fully conducted. We investigated intra‐fractional motion management in breath‐hold Ethos‐based CT‐STAR and CT‐SBRT (stereotactic body non‐adaptive radiotherapy) using optical surface imaging combined with onboard CBCTs. Methods Ten cancer patients with mobile lower lung or upper abdominal malignancies participated in an IRB‐approved clinical trial (Phase I) of optical surface image‐guided Ethos CT‐STAR/SBRT. In the clinical trial, a pre‐configured gating window (± 2 mm in AP direction) on optical surface imaging was used for manually triggering intra‐fractional CBCT acquisition and treatment beam irradiation during breath‐hold (seven patients for the end of exhalation and three patients for the end of inhalation). Two inter‐fractional CBCTs at the ends of exhalation and inhalation in each fraction were acquired to verify the primary direction and range of the tumor/imaging‐surrogate (donut‐shaped fiducial) motion. Intra‐fractional CBCTs were used to quantify the residual motion of the tumor/imaging‐surrogate within the pre‐configured breath‐hold window in the AP direction. Fifty fractions of Ethos RT were delivered under surface image‐guidance: Thirty‐two fractions with CT‐STAR (adaptive RT) and 18 fractions with CT‐SBRT (non‐adaptive RT). The residual motion of the tumor was quantified by determining variations in the tumor centroid position. The dosimetric impact on target coverage was calculated based on the residual motion. Results We used 46 fractions for the analysis of intra‐fractional residual motion and 43 fractions for the inter‐fractional motion analysis due to study constraints. Using the image registration method, 43 pairs of inter‐fractional CBCTs and 100 intra‐fractional CBCTs attached to dose maps were analyzed. In the motion range study (image registration) from the inter‐fractional CBCTs, the primary motion (mean ± std) was 16.6 ± 9.2 mm in the SI direction (magnitude: 26.4 ± 11.3 mm) for the tumors and 15.5 ± 7.3 mm in the AP direction (magnitude: 20.4 ± 7.0 mm) for the imaging‐surrogate, respectively. The residual motion of the tumor (image registration) from intra‐fractional breath‐hold CBCTs was 2.2 ± 2.0 mm for SI, 1.4 ± 1.4 mm for RL, and 1.3 ± 1.3 mm for AP directions (magnitude: 3.5 ± 2.1 mm). The ratio of the actual dose coverage to 99%, 90%, and 50% of the target volume decreased by 0.95 ± 0.11, 0.96 ± 0.10, 0.99 ± 0.05, respectively. The mean percentage of the target volume covered by the prescribed dose decreased by 2.8 ± 4.4%. Conclusion We demonstrated the intra‐fractional motion‐managed treatment strategy in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT. While the controlled residual tumor motion measured at 3.5 mm exceeded the predetermined setup value of 2 mm, it is important to note that this motion still fell within the clinically acceptable range defined by the PTV margin of 5 mm. Nonetheless, additional caution is needed with intra‐fractional motion management in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT.

Analysis of sagittal plane cine magnetic resonance imaging for measurement of pancreatic tumor residual motion during breath hold and evaluation of gating margins used in radiotherapy treatment

Evaluation of Inter- and Intra-Fractional Pancreas Tumor Residual Motions with Abdominal Compression

Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study

Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI

Accuracy and Efficiency of Respiratory Gating Comparable to Deep Inspiration Breath Hold for Pancreatic Cancer Treatment

Feasibility of surface‐guidance combined with CBCT for intra‐fractional breath‐hold motion management during Ethos RT

The impact of motion on onboard MRI-guided pencil beam scanned proton therapy treatments

Investigating the Feasibility of Rapid MRI for Image-Guided Motion Management in Lung Cancer Radiotherapy

Planning Target Volume Margin Definition from Image Guided Hypofractionated Radiation Therapy for Pancreatic Cancer

Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy

Impact of Respiratory-gated 4D PET/CT Scan for Motion Correction in Characterizing Lesions Adjacent to the Diaphragm - A Cross-sectional Study at a Tertiary Care Institute

Abdominal and Pancreatic Motion Correlation Using 4D CT, 4D Transponders, and a Gating Belt.

Modeling intra-fractional abdominal configuration changes using breathing motion-corrected radial MRI

Combining rescanning and gating for a time-efficient treatment of mobile tumors using pencil beam scanning proton therapy

Clinical experience with adaptive MRI-guided pancreatic SBRT and the use of abdominal compression to reduce treatment volume

Impacts of lesion angle on incidence and distribution of acute vessel wall injuries and strut malapposition after drug-eluting stent implantation assessed by optical coherence tomography.

Simultaneous Motion Monitoring and Truth-In-Delivery Analysis Imaging Framework for MR-guided Radiotherapy

Assessing target localization accuracy across different soft-tissue matching protocols using end-exhalation breath-hold cone-beam computed tomography in patients with pancreatic cancer

Investigating the use of virtual 4DCT from 4DMRI in gated carbon ion radiation therapy of abdominal tumors

Study on Motion Management of Pancreatic Cancer Treated by CyberKnife

Respiratory Motion-Resolved, Self-Gated 4D-MRI Using Rotating Cartesian K-space (ROCK): Initial Clinical Experience on an MRI-guided Radiotherapy System